Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2015 | 1 |
2016 | 1 |
2017 | 2 |
2018 | 1 |
2019 | 2 |
2020 | 1 |
2021 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Phosphorylation of the MNK1 substrate eIF4E is not required for response to acute pancreatitis.
Pancreatology. 2021 Jun;21(4):677-681. doi: 10.1016/j.pan.2021.02.013. Epub 2021 Feb 19.
Pancreatology. 2021.
PMID: 33648878
Free article.
eIF4A inhibition circumvents uncontrolled DNA replication mediated by 4E-BP1 loss in pancreatic cancer.
Müller D, Shin S, Goullet de Rugy T, Samain R, Baer R, Strehaiano M, Masvidal-Sanz L, Guillermet-Guibert J, Jean C, Tsukumo Y, Sonenberg N, Marion F, Guilbaud N, Hoffmann JS, Larsson O, Bousquet C, Pyronnet S, Martineau Y.
Müller D, et al. Among authors: strehaiano m.
JCI Insight. 2019 Nov 1;4(21):e121951. doi: 10.1172/jci.insight.121951.
JCI Insight. 2019.
PMID: 31672935
Free PMC article.
Item in Clipboard
Learning performances and vulnerability to amyloid toxicity in the butyrylcholinesterase knockout mouse.
Maurice T, Strehaiano M, Siméon N, Bertrand C, Chatonnet A.
Maurice T, et al. Among authors: strehaiano m.
Behav Brain Res. 2016 Jan 1;296:351-360. doi: 10.1016/j.bbr.2015.08.026. Epub 2015 Aug 22.
Behav Brain Res. 2016.
PMID: 26306824
Item in Clipboard
FAK activity in cancer-associated fibroblasts is a prognostic marker and a druggable key metastatic player in pancreatic cancer.
Zaghdoudi S, Decaup E, Belhabib I, Samain R, Cassant-Sourdy S, Rochotte J, Brunel A, Schlaepfer D, Cros J, Neuzillet C, Strehaiano M, Alard A, Tomasini R, Rajeeve V, Perraud A, Mathonnet M, Pearce OM, Martineau Y, Pyronnet S, Bousquet C, Jean C.
Zaghdoudi S, et al. Among authors: strehaiano m.
EMBO Mol Med. 2020 Nov 6;12(11):e12010. doi: 10.15252/emmm.202012010. Epub 2020 Oct 7.
EMBO Mol Med. 2020.
PMID: 33025708
Free PMC article.
Item in Clipboard
Neuroprotection in non-transgenic and transgenic mouse models of Alzheimer's disease by positive modulation of σ1 receptors.
Maurice T, Volle JN, Strehaiano M, Crouzier L, Pereira C, Kaloyanov N, Virieux D, Pirat JL.
Maurice T, et al. Among authors: strehaiano m.
Pharmacol Res. 2019 Jun;144:315-330. doi: 10.1016/j.phrs.2019.04.026. Epub 2019 Apr 29.
Pharmacol Res. 2019.
PMID: 31048034
Item in Clipboard
Amyloid toxicity is enhanced after pharmacological or genetic invalidation of the σ1 receptor.
Maurice T, Strehaiano M, Duhr F, Chevallier N.
Maurice T, et al. Among authors: strehaiano m.
Behav Brain Res. 2018 Feb 26;339:1-10. doi: 10.1016/j.bbr.2017.11.010. Epub 2017 Nov 9.
Behav Brain Res. 2018.
PMID: 29129596
Item in Clipboard
An Intranasal Formulation of Erythropoietin (Neuro-EPO) Prevents Memory Deficits and Amyloid Toxicity in the APPSwe Transgenic Mouse Model of Alzheimer's Disease.
Rodríguez Cruz Y, Strehaiano M, Rodríguez Obaya T, García Rodríguez JC, Maurice T.
Rodríguez Cruz Y, et al. Among authors: strehaiano m.
J Alzheimers Dis. 2017;55(1):231-248. doi: 10.3233/JAD-160500.
J Alzheimers Dis. 2017.
PMID: 27662300
Item in Clipboard
Cite
Cite